SEC Form 4 · accession 0000899243-16-026439
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gert L. Perlhagen
Director · 10% Owner
Period of report
Aug 5, 2016
Accepted (ET)
Aug 5, 2016 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 5, 2016 | J | 676,576 | $0.00 | A | 676,576 | D | |
| Ordinary SharesF2 | Aug 5, 2016 | S | 110,000 | $1.82 | D | 566,576 | D | |
| Ordinary SharesF2 | Aug 5, 2016 | S | 334,243 | $1.65 | D | 232,333 | D | |
| Ordinary SharesF2 | Aug 5, 2016 | S | 69,560 | $2.15 | D | 162,773 | D | |
| Ordinary SharesF2 | Aug 5, 2016 | S | 16,893 | $2.16 | D | 145,880 | D | |
| Ordinary SharesF2 | Aug 5, 2016 | S | 52,667 | $2.16 | D | 93,213 | D | |
| Ordinary SharesF2 | Aug 5, 2016 | S | 69,560 | $2.15 | D | 23,653 | D | |
| Ordinary SharesF2 | Aug 5, 2016 | S | 5,913 | $2.11 | D | 17,740 | D | |
| Ordinary SharesF2 | Aug 5, 2016 | S | 17,740 | $2.17 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Distribution from Oden Trust.
- F2Transferred by Mr. Perlhagen in accordance with a historical obligation to the recipient.